Skip to content

Clinical trials

Phase 2/3 Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Infections Phase: Phase 2/3 Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20091
20101
20111
20122
20141
20152
20181
20192
20203
20211
20223
20231
20257

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting7
Unknown status2
Active, not recruiting1
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Monash University5
Drugs for Neglected Diseases3
Forest Laboratories2
AN2 Therapeutics, Inc1
Abbott1
Barts & The London NHS Trust1
Beijing Tiantan Hospital1
Centre de Maternité de Monastir1
Columbia University1
Danish Procalcitonin Study Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Infections30
Leukemia5
Lymphoma5
Neoplasms5
Neoplasms, Plasma Cell5
Surgical Wound Infection3
Trypanosomiasis, African3
Wounds and Injuries3
Agammaglobulinemia2
Bacterial Infections2

Trials

Showing 51 to 30 of 30. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.